Dr. Chen is he a fellowship-trained medical oncologist, as well as an expert in sophisticated bioinformatics techniques. He has been involved in genomics and complex computational modeling of biological data for nearly a decade. Dr. Chen focuses in the fields of translational bioinformatics (applying computer science techniques to genetic data) and integrative genomics (meaningfully merging a patient's medical data with his or her genomic information) as applied to cancer. He is particularly interested in the personalization of medicine through the development of novel biomarkers of molecular pathway activation using automated, high-throughput genomic techniques. These biomarkers may ultimately assist clinicians in customizing treatment regimens for their patients. Dr. Chen has a clinical research interest in prostate, bladder, kidney, and sarcoma cancers. Dr. Chen is currently exploring drug treatments targeting the Jak2/Stat3 pathway and the homeobox genes Meis1 and Meis2 in prostate cancer. In addition, he is also developing a next-generation database that can potentially predict cancer recurrence.